Clashes in French parliament over sickness bill:
This article was originally published in Clinica
The French government's bill on the reform of sickness insurance has now begun what is anticipated to be a lengthy journey through the parliamentary process. There have already been angry exchanges in the Chamber of Deputies on the decree which introduces the biggest single reform of the system in over a decade, and contains measures which could have a negative impact on the profits of medical devices and diagnostics manufacturers (see Clinica Nos 1112, p 6 and 1113, p 3).
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.